Loading...
•
Mar 31, 2020
DuPont Q1 2020 Earnings Report
DuPont's first quarter results were announced, showing a decrease in GAAP EPS and net sales, but demonstrating strength in Electronics & Imaging and Nutrition & Biosciences segments.
Key Takeaways
DuPont reported a decrease in net sales and GAAP EPS, but managed to exceed initial expectations in its core segments. The company is focused on managing working capital and aligning production with demand, while also strengthening its balance sheet.
GAAP EPS from continuing operations was $(0.83); adjusted EPS was $0.84.
Net sales were $5.2 billion, down 4 percent; organic sales down 2 percent.
The company further strengthened liquidity with a $1.0 billion revolving credit facility.
Initiatives were implemented to mitigate the impact of COVID-19, including actions to deliver more than $500 million of working capital improvement and reducing capital expenditures by ~$500 million versus the prior year.
Revenue by Geographic Location
Forward Guidance
DuPont is prioritizing the safety and health of its employees, maintaining operations, strengthening its balance sheet, and partnering with other industry leaders to combat the pandemic. The company is focused on optimizing working capital, deferring capital expenditures, improving its cost structure, and strengthening its liquidity.
Positive Outlook
- Strength in personal protection
- Strength in water filtration
- Strength in food and beverage
- Strength in electronics
- Strength in probiotics
Challenges Ahead
- Automotive sector suffering
- Oil and gas sector suffering
- Select industrial end markets suffering
- Impossible to predict timing of market stabilization
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...